The Ameliorative Effect of Rubi Fructus on DSS-induced Colitis in Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Ulcerative colitis (UC) is an inflammatory bowel disease and a chronic gastrointestinal disorder. Rubi Fructus (RF), the fruit of Rubus coreanus Miquel, is known to exert several pharmacological effects including anti-oxidative, anti-obesity and anti-inflammatory properties. However, the improving effect and mechanism of RF on intestinal inflammation is not been fully understood. The purpose of this study was to investigate the regulatory effect of RF on dextran sulfate sodium (DSS)-induced colitis in mice. We evaluated the effects of RF on DSS-induced clinical signs by analyzing weight loss and colon length. The inhibitory effects of RF on inflammatory mediators such as prostaglandin E2 (PGE2), cyclooxygenase (COX)-2, as well as the activation of nuclear factor-κB (NF-κB), were determined in colitis tissue. Our data indicated that mice treated with DSS showed clinical symptoms of colitis, including weight loss, colon length decrease and diarrhea. However, we observed that RF treatment significantly improved these clinical symptoms of weight loss, colon length decrease and diarrhea induced by DSS. RF inhibited the enhanced levels of COX-2 and PGE2 caused by DSS. We also showed that the anti-inflammatory mechanism of RF by suppressing the activation of NF-kB in DSS-treated colon tissues. Collectively, the findings of this study indicate the prospect of developing new drugs from RF for UC treatment.
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease and a chronic gastrointestinal disorder. Rubi Fructus (RF), the fruit of Rubus coreanus Miquel, is known to exert several pharmacological effects including anti-oxidative, anti-obesity and anti-inflammatory properties. However, the improving effect and mechanism of RF on intestinal inflammation is not been fully understood. The purpose of this study was to investigate the regulatory effect of RF on dextran sulfate sodium (DSS)-induced colitis in mice. We evaluated the effects of RF on DSS-induced clinical signs by analyzing weight loss and colon length. The inhibitory effects of RF on inflammatory mediators such as prostaglandin E2 (PGE2), cyclooxygenase (COX)-2, as well as the activation of nuclear factor-κB (NF-κB), were determined in colitis tissue. Our data indicated that mice treated with DSS showed clinical symptoms of colitis, including weight loss, colon length decrease and diarrhea. However, we observed that RF treatment significantly improved these clinical symptoms of weight loss, colon length decrease and diarrhea induced by DSS. RF inhibited the enhanced levels of COX-2 and PGE2 caused by DSS. We also showed that the anti-inflammatory mechanism of RF by suppressing the activation of NF-kB in DSS-treated colon tissues. Collectively, the findings of this study indicate the prospect of developing new drugs from RF for UC treatment.
참고문헌 (25)
- Agoff, S. N., "The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia", Am. J. Pathol, 157, pp.737~745 (2000)
- Ardizzone, S., "Biologic therapy for inflammatory bowel disease", Drugs, 65, pp.2253~2286 (2005)
- Atreya, I., "NF-kappa B in inflammatory bowel disease", J. Intern. Med, 263, pp.591~596 (2008)
- Baumgart, D. C., "Inflammatory bowel disease : Cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- Danese, S., "Inflammatory bowel disease; the role of environmental factors", Autoimmun. Rev, 3, pp.394~400 (2004)
- Domenech, E., "Inflammatory bowel disease: Current therapeutic options", Digestion, 73, pp.67~76 (2006)
- Ferrer, M. D., "Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases", Curr. Med. Chem, 26, pp.3225~3241 (2019)
- He, J. M., "Suppression of nuclear factor-kappa B and mitogen-activated protein kinase signalling pathways by goshonoside-F5 extracted from Rubi Fructus", Int. Immunopharmacol, 24, pp.182~190 (2015)
- Hendrickson, B. A., "Clinical aspects and pathophysiology of inflammatory bowel disease", Clin. Microbiol. Rev, 15, pp.79~94 (2002)
- Hudcovic, T., "The role of microflora in the development of intestinal inflammation: Acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice", Folia Microbio, 46, pp.565~572 (2001)
- Jeong, M. Y., "Rubi Fructus (Rubus coreanus) activates the expression of thermogenic genes in vivo and in vitro", Int. J. Obes. (Lond), 39, pp.456~464 (2015)
- 정성희, "국내유통 복분자와 토종복분자의 이화학적 특성과 엘라그산 함량 비교연구", 한국자원식물학회지, 34(2), pp.177~185 (2021), 한국자원식물학회
- Li, Y., "COX-2-PGE(2) signaling impairs intestinal epithelial regeneration and associates with TNF inhibitor responsiveness in ulcerative colitis", EBioMedicine, 36, pp.497~507 (2018)
- Lin, X., "Colonic epithelial mTORC1promotes ulcerative colitis through COX-2-mediated Th17responses", Mucosal. Immunol, 11, pp.1663~1673 (2018)
- Nam, M. K., "Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice", Mol. Med. Rep, 10, pp.1821~1827 (2014)
- Periasamy, S., "Dietary Ziziphus jujuba fruit attenuates colitis-associated tumorigenesis: A pivotal role of the NF-kappaB", IL-6, STAT3 pathway, pp.Nutr. Cancer., 2020[DOI]
- Ramakers, J. D., "The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis", J. Clin. Immunol, 27, pp.275~283 (2007)
- Roberts, P. J., "Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease", Gut, 48, pp.468~472 (2001)
- Rogler, G., "Nuclear factor kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa", Gastroenterology, 115, pp.537~569 (1998)
- Sandborn, W. J., "Biologic therapy of inflammatory bowel disease", Gastroenterology, 122, pp.1592~1608 (2002)
- Skupsky, J., "Biotin supplementation ameliorates murine colitis by preventing NF-kappaB activation", Cell. Mol. Gastroenterol. Hepatol, 9, pp.557~567 (2020)
- Tak, P.P., "NF-κB: A key role in inflammatory disease", J. Clin. Invest, 107, pp.7~11 (2001)
- Tsuge, K., "Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases", Int. Immunol, 31, pp.597~606 (2019)
- Wirtz, S., "Chemically induced mouse models of acute and chronic intestinal inflammation", Nat. Protoc, 12, pp.1295~1309 (2017)
- Yashiro, M., "Ulcerative colitis-associated colorectal cancer", World. J. Gastroenterol, 20, pp.16389~16397 (2014)
